March 25, 2019 — Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented at ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
March 19, 2019 — The Bristol-Myers Squibb-Pfizer Alliance announced results from the Phase 4 AUGUSTUS trial evaluating ...
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 ...
March 18, 2019 — The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a ...
February 19, 2019 — A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and ...
February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...
January 31, 2019 — Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target ...
Here are a few of the takeaways from the clinical studies presented and new technology shown on the exhibit floor at the ...
January 10, 2019 — Aurobindo Pharma USA Inc. is conducting a voluntary recall of 80 lots of Amlodipine Valsartan Tablets ...
January 4, 2018 — Here is the top cardiology content on the Diagnostic and Interventional Cardiology (DAIC) website from ...
January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...
January 2, 2019 — The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval ...
December 17, 2018 — Among otherwise healthy people, a daily dose of aspirin does not save lives and causes additional ...
December 11, 2018 — Mylan Pharmaceuticals is expanding its consumer-level voluntary nationwide recall to include all ...